Literature DB >> 7503607

Referral for dialysis in Ontario.

D C Mendelssohn1, B T Kua, P A Singer.   

Abstract

BACKGROUND: Because the incidence rates of treated end-stage renal disease are much lower in Canada than in the United States, we hypothesized that decisions, made by family physicians and community internists, not to refer certain patients to nephrologists might explain this difference.
OBJECTIVE: To elicit patterns of practice and attitudes from nonnephrologist physicians who care for, and possibly refer, patients with renal disease.
METHODS: A mailed survey was sent to a random sample of 1924 members of the Ontario Medical Association, Sections on General and Family Practice and Internal Medicine. Of 1778 eligible respondents, responses were received from 728 physicians (40.9%).
RESULTS: Patients with microscopic hematuria (79.2%), proteinuria (69.5%), and serum creatinine levels in the 120 to 150 mumol/L (1.4 to 1.7 mg/dL) range (84.3%) were generally not referred by family physicians. A hypothetical question about patient age and comorbid features revealed that physicians were less likely to refer patients as their age and comorbidity increased. In response to the question, "In the past 3 years, did you care for a patient who, after due consideration, died of renal failure without referral for dialysis," 14.2% of family physicians and 44.6% of internists said yes. Overall, 67.4% of respondents strongly or somewhat agree that rationing of dialysis is occurring now. Opinions about possible criteria for rationing of dialysis were that the majority strongly or somewhat agreed to basing a decision on the wishes of a competent patient (94.1%), short life expectancy (87.9), poor quality of life (87.0%), and age (63.6%).
CONCLUSIONS: These results suggest that nonreferral for dialysis occurs in Ontario and that the act of referral, or nonreferral as the case may be, is influenced by both age and coexisting disease. The patterns of nonreferral reported raise a concern that patients who might benefit are not being referred to dialysis centers.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1995        PMID: 7503607

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  End-stage renal disease. Timely, appropriate treatment is crucial.

Authors:  R Wilson; M Godwin
Journal:  Can Fam Physician       Date:  2000-03       Impact factor: 3.275

2.  Elevated levels of serum creatinine. Guidelines for management and referral. Canadian Society of Nephrology.

Authors: 
Journal:  Can Fam Physician       Date:  2000-03       Impact factor: 3.275

Review 3.  Sex or body size? Selection of dialysis type revisited.

Authors:  A Levin
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

4.  Primary care management of chronic kidney disease.

Authors:  Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist
Journal:  J Gen Intern Med       Date:  2010-10-05       Impact factor: 5.128

Review 5.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

6.  Natural history of elevated creatinine levels.

Authors:  Laura Marcotte; Marshall Godwin
Journal:  Can Fam Physician       Date:  2006-10       Impact factor: 3.275

7.  Prevalence and determinants of physician bedside rationing: data from Europe.

Authors:  Samia A Hurst; Anne-Marie Slowther; Reidun Forde; Renzo Pegoraro; Stella Reiter-Theil; Arnaud Perrier; Elizabeth Garrett-Mayer; Marion Danis
Journal:  J Gen Intern Med       Date:  2006-07-07       Impact factor: 5.128

8.  Factors associated with initiation of chronic renal replacement therapy for patients with kidney failure.

Authors:  Labib I Faruque; Brenda R Hemmelgarn; Natasha Wiebe; Braden J Manns; Pietro Ravani; Scott Klarenbach; Rick Pelletier; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 8.237

9.  The costs and benefits of automatic estimated glomerular filtration rate reporting.

Authors:  Julia R den Hartog; Peter P Reese; Borut Cizman; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

10.  A comparison of cardiovascular procedure use between the United States and Canada.

Authors:  D K Verrilli; R Berenson; S J Katz
Journal:  Health Serv Res       Date:  1998-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.